Data silos are a major roadblock in tech transfer, creating inefficiencies and slowing down the entire process. ? Exclusive Webinar: Join ZAETHER on December 3rd 12:00 PM EDT / 5 PM GMT / 6 PM CET as part of BPI Fall and Viral Vectors Digital Week. Unlocking the power of MES in Bioprocessing: how digital solutions can integrate all data across phases, ensuring that your manufacturing process is seamless and transparent.? ? Register now: https://lnkd.in/e834xf3e ? #DataSilos #TechTransfer #DigitalSolutions #LifeSciences #Zaether?#Webinar #biophorum
关于我们
The Stellix Group of companies share a common mission of providing transformative solutions at the intersection of science and technology that enable our customers to deliver a healthier and more sustainable future. Our unique portfolio of companies is focused on helping life sciences and industry manufacturers build, connect, and transform operations and IT to make real progress in breakthrough therapeutics, food, energy, and more.
- 网站
-
https://stellix.com
The Stellix Group的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 201-500 人
- 总部
- Foxborough (Foxboro)，Massachusetts
- 类型
- 私人持股
- 领域
- Industrial Automation Services、Industrial Digital Transformation Consulting和Life Sciences Process and Manufacturing Digital Transformation
地点
-
主要
获取路线
325 Foxborough Blvd
US，Massachusetts，Foxborough (Foxboro)，02035
The Stellix Group员工
动态
-
Happy Friday everyone! Sharing a recent article from our CEO Jenn Azar. Enjoy...and see comments for a link to more thought leadership content on the Stellix website.
CEO of Stellix | President of NECI | Future-focused Solutions for Life Sciences, Energy, and Industrial Manufacturing
“Running on paper” or “Paper silos” will not cut it anymore for drug manufacturers. With AI driving rapid therapy development, life sciences manufacturers need to digitize. FAST. Data has to move at the same speed as production. Without digital solutions, compliance slows, and time to market drags. We need systems that can keep up with emerging therapies, not hold them back. Digitization isn’t optional—it’s essential for staying ahead. See what I propose for a new and improved operational model: https://lnkd.in/eb76vUnx #digitization #AI #lifesciences #innovation #manufacturing #digitaltransformation
-
Stellix recently wrapped up FY24 with our Quarterly Shareholders Meeting, where we reflected on our progress as an ESOP and shared our plans for the future. We’re proud of the hard work that fueled our accomplishments this past year and are very excited about the initiatives we set for FY25.?These initiatives will help us continue driving innovation and growth—not just for Stellix, but for our customers as well!
-
-
The COVID-19 pandemic placed biomakers under enormous pressure. Moderna had to increase its production exponentially by 2000% during the pandemic. How? They achieved this by implementing MES, which enabled: ● Real-time tracking of production ● Quick adaptation to changing needs ● Flexibility in batch recipes Want to know how MES can help your company achieve similar results?? https://lnkd.in/e8kDU4tg
-
-
See the latest thoughts from our CEO Jenn Azar on operating at the speed of life science innovation through digital-first workforce transformation. We'd love to hear your thoughts on this article. Send us a comment! ZAETHER NECI Stellix Global Services
CEO of Stellix | President of NECI | Future-focused Solutions for Life Sciences, Energy, and Industrial Manufacturing
Technology alone can’t keep up with the speed of science. Recent years have brought significant scientific innovation—think mRNA, CAR T, and CRISPR/Cas9. The existing manufacturing facilities were built for a very different business model and outcome.? We are moving towards smaller volume, more personalized treatments, which will require transformation in the way we design and operate manufacturing to deliver new therapeutics. So, how can we get the latest and greatest therapies into the hands of those who need them? It’s not as simple as upgrading to newer production equipment (though that is part of it).? It also involves transforming your workforce and methodologies to embrace more robust digitized solutions. Curious to learn more? Check out my latest piece: https://lnkd.in/e9e2KuWw
Navigating the Complexity of New Drug Modalities
stellix.com
-
We’re excited to kick off this collaboration with Seeq Corporation! Working together, we’re setting the stage for the next generation of digital services in Biopharma—bringing new possibilities for efficiency and innovation.? ? If you’re interested in exploring solutions to your challenges, please visit: https://lnkd.in/e5CwHRKP NECI The Stellix Group
A world of thanks to team ZAETHER for their warm welcome as we launch a great partnership in the Life Sciences vertical! Excited to collaborate with Jenn Azar, Jason Winkler, Jay Upadhyay, Samantha Szatek, Philip Braun, Roman Rodriguez Vincent, Greg Ladwig and the Zaether team. Thanks to many Seeqers including Dede Davis, Michael Bartlett, Ben Bishop and Paolo Braiuca for support of this partnership. And most importantly, together ZAETHER and Seeq Corporation will bring a strong ecosystem to Life Sciences companies who have goals of increasing production, achieving sustainability targets and ensuring patient safety.
-
-
CEO of Stellix | President of NECI | Future-focused Solutions for Life Sciences, Energy, and Industrial Manufacturing
The Boston life sciences community is nothing short of remarkable. It’s a place where science and compassion coexist. Where every discovery has the potential to change lives. Being part of this community isn’t a career. >> It’s a calling. << It’s about being a steward of hope and possibility. It’s a belief that through our work, we can make the world a better place for those who need it most. https://lnkd.in/esaJNYqi #lifesciences #boston #innovation #community
A Love Letter to the Boston Life Sciences Community
stellix.com
-
Huge congratulations to BioversityMA on the graduation of its 5th cohort! Your dedication to advancing workforce development and creating highly skilled professionals in the life sciences industry is truly inspiring. Each cohort represents a new wave of talent, innovation, and commitment that strengthens our field. Watching these graduates take the next steps in their careers, equipped with cutting-edge knowledge and skills, is a testament to Bioversity's impactful training and support. Here’s to celebrating the graduates' achievements and the many future cohorts that will follow! #Bioversity #LifeSciences
We celebrated our fifth and final cohort graduation of 2024 yesterday, marking one year of Bioversity operations! Thank you to everyone who has supported us on this journey and make this program possible. Special thank you to our graduation speakers: - John Moran, State Representative, Massachusetts Ninth Suffolk District - Ronald Marlow, VP, Workforce Development & Alternative Education, Action for Boston Community Development, Inc. - Jeanne LeClair, VP of Economic Development & Partnerships, Massachusetts Life Sciences Center We are so proud of this cohort and all of our graduates for what they have achieved this year. Learn more: https://lnkd.in/eygHPSfV Zach Stanley Ross Marshall
-
-
-
-
-
+3
-
-
Today we remember the tragic events of September 11, 2001, and honor the lives lost, the bravery of first responders, and the resilience of families and communities affected by that day. ? We are reminded of the strength that comes from unity, the support of our communities, and the spirit of perseverance. ? #Peace #Unity #NeverForget #PatriotDay
-